NVAX trade ideas
$NVAX - Gap up playGM traders! Hope you had a nice Memorial Day Weekend.
$NVAX gapping up +20% this morning, covid-19 vaccine play, phase 1 clinical trial news.
2 ways to play this:
1. look to short at premarket high and top of resistance area before the daily gap up, anywhere between 58.62 (PM high) and 61.50, target price is premarket low around 53 area. Risk 1: Reward 6
2. look to go long after breaking resistance area, and pull back. +80% gap fill within 2 days, enter near 60 area and target 80. Risk 3: Reward 20
NVAX GAP UPa week ago NVAX received $388M in funding pushing the stock up to ath of $61.50. I would say profit taking pushed the stock down to its current level @ $46-ish. Recent news on new human trials to begin in July enough to Push stock back up ATH? Any feedback would be awesome.
(disclaimer: This is only my second Publish lol)
NVAX: $55+ Target very Reasonable, hoping for around $65First off, please don't take anything I say seriously or as financial advice. As always, this is on opinion based basis. That being said, I have a few quick insights. Novavax is about to start the human clinical trials for a Coronavirus vaccine, and the recent already expected price retracement by investors, the strong buy rating, and the positive news may have this stock start to rally and you might want to consider this as a buy pre-market hours even.
Novavax Technical and Fundamental AnalysisTechnical Analysis - Check/wait if one of the supports will not be broken before buying
On a daily chart there might be a Bottom Saucer or Rounding Reversal Pattern
Fundamental News:
Novavax (NASDAQ:NVAX) is a clinical-stage biotechnology company focused on the discovery, development and commercialisation of vaccines and adjuvants. Through its recombinant nanoparticle vaccine technology, it produces vaccine candidates to respond to both known and newly emerging diseases.
Novavax topped Wall Street expectations for the first quarter when it reported a loss of 58 cents per share on revenue of $3.4 million earlier this month. Analysts were expecting a loss of 69 cents per share and revenue of $1.9 million.
More importantly, the biotech company announced in its earnings release that the Oslo-based nonprofit Coalition for Epidemic Preparedness Innovations will invest $384 million to advance the clinical development of its SARS-CoV-2 vaccine candidate, NVX-CoV2373.
Novavax plans to start human trials in May with preliminary results expected in July.
NVAX a buy?NVAX isn't a buy for me because I don't like to buy stocks that are overbought. But if your a risky investor this is for you. NVAX when overbought has only recently gone down by $8. Then it goes right back up. The purple arrow is where I think it will go I the next 5-10 days. PLEASE COMMENT WHAT YOU THINK!
[NVAX] Sliding Back to $40, Collapse if It Breaks ThroughI missed this guy when I jumped on MRNA and INO earlier this week.
Just trying to pin this one down a bit, coronavirus stocks are wild and fun :).
For FOMO stocks, typical support and resistance horizontal lines aren't as predictive and you should instead look to the Volume Profile.
Support should be right around the POC, which is $40.
It should slide down to that and hang a bit before breaking through and crashing down. May bounce back up too but seems unlikely.
All indicators are lining up at the start of a downward channel and signaling a short move too.
June market crash is probably gonna move this more than anything as retail tries to secure their tiny profits or stem their massive losses.
$NVAX can rise in the next daysContextual immersion trading strategy idea.
Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases.
The share price rose after good earnings. I see some preconditions the share price will continue growing.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $43,15;
stop-loss — $42,26.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Vaccine candidates seeing huge gains.A good trade to consider is vaccine development companies. Some of the major players are Novavax, Moderna and Giliad. A conservative price target might be 15-25%.
Novavax (NVAX): Tell me about my Schiff!I'm bull-ish on Novavax (see Related Idea). I think their approach to the COVID-19 vaccine is promising - their recombinant nanoparticle vaccine technology and Matrix-M adjuvant. They also have positive long-term prospects with their proprietary NanoFlu candidate. This is the big one to me. It's unclear whether COVID-19 becomes seasonal or not but influenza is established and recurring. It fact, it's becoming more difficult to handle with every year. The strains are becoming more advanced and unpredictable. Whether or not Novavax can produce a profitable candidate, I simply don't know. I believe that their patented tech is promising.
Novavax might not produce a COVID vaccine before its competitors (or at all) but they continue to demonstrate their technology and approach works. Example: ir.novavax.com
That being said, tell me about this random Schiff I plotted :)
Matrix-M Adjuvant: novavax.com
NanoFlu Phase 3 topline data: novavax.com
RSV F Vaccine: novavax.com
Novavax Big Break Out Day!- $NVAX, +30.80% as it rallied after the biotech announced it received a large $384m investment for its COVID-19 vaccine candidate and beat Earnings expectations.
- Technically we are in a strong uptrend - just broken out of its corrective move down. This is the type of stock which may take off further quite quickly - we could wait for a pullback (possibly at the old highs) or buy this breakout at the open market. Will depend on your risk appetite.
- Targets have been set based on the Pitchforks and Median Line Theory.
NVAX - Setting up nicely for ShortWith 100% implied volatility - and 3 month options costing 225% of Implied Vol. You can safely bet on a short, soon you pick the top with your fav strategy.
Analysis -
This whole run up is for a huge offering.
Company has no cash or cash equivalent.
Upcoming obligations - $342k + unknown research cost and operating expenses.
If I read this correctly, About 4.9M shares are going to be dumped (Around $30 peak, or before) Soon will roll down. - Looking for 3 month mark.
secfilings.nasdaq.com
secfilings.nasdaq.com
NVAX great swing into earnings. Go long, tight stop. NASDAQ:NVAX is giving us a great swing trade setup. few days to print. VWAP, fast MA, med MA sitting above slow MA for a long time and offering up a beautiful retracement that will bounce off the indicators right before earnings. Go long, and set a stop where VWAP gets crossed down by the fast MA AND the med MA. Should bring a 4:1 profit to risk ratio.
NVAX Round UpNVAX has held its 13sma and is now looking to round up to reach its old high resistance level around the $24 range. I only plan on being in this until 4/30, due to earnings being reported after the bell
NVAX - Potential WAVE 1 of larger move up!See Descriptions on Chart.
We may be headed higher if resistance line is broken. I'll post additional screenshot of Momentum moving us lower before we go up again. Volume is not as high as we want to break the line just yet but we could just be catching our breath.
I'm staying on the sidelines on the long side until Resistance line is broken, but could be a decent shorting opportunity if we bounce off of resistance again.
Bullish Pennant on novavax 30 min chartLooks like Novavax is consolidating for a strong move upward. NASDAQ:NVAX
